Keith C. Ferdinand , Diane Orenstein , Yuling Hong , Joann G. Journigan , Justin Trogdon , Jennifer Bowman , Armineh Zohrabian , Meredith Kilgore , Alexander White , Ali Mokdad , Terry F. Pechacek , Ron Z. Goetzel , Darwin R. Labarthe , Gary A. Puckrein , Eric Finkelstein , Guijing Wang , Molly E. French , Viola Vaccarino
{"title":"Health economics of cardiovascular disease: Defining the research agenda","authors":"Keith C. Ferdinand , Diane Orenstein , Yuling Hong , Joann G. Journigan , Justin Trogdon , Jennifer Bowman , Armineh Zohrabian , Meredith Kilgore , Alexander White , Ali Mokdad , Terry F. Pechacek , Ron Z. Goetzel , Darwin R. Labarthe , Gary A. Puckrein , Eric Finkelstein , Guijing Wang , Molly E. French , Viola Vaccarino","doi":"10.1016/j.cvdpc.2011.05.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data.</p></div><div><h3>Methods and Results</h3><p>The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda.</p></div><div><h3>Conclusions</h3><p>Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"6 3","pages":"Pages 91-100"},"PeriodicalIF":0.0000,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2011.05.001","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cvd Prevention and Control","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875457011000532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Background
When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data.
Methods and Results
The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda.
Conclusions
Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
